Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Lupus|November 16, 2004
Autoantibodies recognizing the 27 carboxy-terminal amino acids of calpastatin are associated with secondary Sjögren syndrome in systemic lupus erythematosusV Salle, O Vittecoq, F Jouen-Beades, et al.Clinical and Experimental Immunology|February 9, 2007
Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndromeV Goëb, V Salle, P Duhaut, et al.Journal of Cellular Physiology|October 1, 1994
Proliferative responses of epithelial cells to 8-bromo-cyclic AMP and to a phorbol ester change during breast pathogenesisA B Starzec, E Spanakis, A Nehme, et al.Rheumatology (Oxford, England)|December 23, 2008
Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective studyJ Schmidt, P Duhaut, A M Bourgeois, et al.La Revue De Medecine Interne|June 29, 2004
[Angioedema and angiotensin converting enzyme inhibitors: a report of 19 cases]J-P Ducroix, S Outurquin, B Benabes-Jezraoui, et al.Rheumatology (Oxford, England)|October 16, 2001
Autoantibodies to the 27 C-terminal amino acids of calpastatin are detected in a restricted set of connective tissue diseases and may be useful for diagnosis of rheumatoid arthritis in community cases of very early arthritisO Vittecoq, V Salle, F Jouen-Beades, et al.Journal of Reproductive Immunology|September 16, 2016
Antibodies directed against annexin A2 and obstetric morbidityV Salle, J Schmidt, A Smail, et al.European Journal of Internal Medicine|September 4, 2012
Antibodies against the N-terminal domain of annexin A2 in antiphospholipid syndromeV Salle, J C Mazière, A Brulé, et al.Lupus|October 13, 2010
Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosusJ P Lanoix, A M Bourgeois, J Schmidt, et al.Journal of Clinical Immunology|March 7, 2008
Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndromeV Salle, J C Mazière, A Smail, et al.Pageof 3